Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.51 USD | -1.04% |
|
-0.78% | -22.94% |
06-20 | Disc Medicine Insider Bought Shares Worth $3,000,024, According to a Recent SEC Filing | MT |
06-17 | BMO Capital Adjusts Price Target on Disc Medicine to $70 From $50, Maintains Outperform Rating | MT |
Chart calendar Disc Medicine, Inc.
Upcoming events on Disc Medicine, Inc.
Past events on Disc Medicine, Inc.
2024-06-14 12:00 | European Hematology Association Meeting - Abstract No: P1563 |
2024-06-14 12:00 | European Hematology Association Meeting - Abstract No: P1059 |
2024-06-14 12:00 | European Hematology Association Meeting - Abstract No: P1569 |
2024-06-14 12:00 | European Hematology Association Meeting - Abstract No: P1575 |
2024-06-14 08:00 | European Hematology Association Meeting |
2024-06-12 09:00 | Annual General Meeting |
2024-06-06 13:00 | Jefferies Global Healthcare Conference |
2024-05-20 10:30 | H.C. Wainwright BioConnect Investor Conference |
2024-05-09 08:00 | Q1 2024 Earnings Release |
2024-04-01 08:30 | AURORA Phase 2 Study Topline Results Call |
2024-03-21 08:00 | Q4 2023 Earnings Release |
2024-03-11 10:40 | Leerink Partners Global Biopharma Conference |
2024-01-10 17:15 | JPMorgan Healthcare Conference |
2023-12-11 21:30 | American Society of Hematology Meeting |
2023-12-11 21:00 | American Society of Hematology Meeting - Abstract Number: 4564 |
2023-12-11 20:30 | American Society of Hematology Meeting - Abstract Number: 923 |
2023-12-08 | American Society of Hematology Meeting - Abstract Number: 5228 |
2023-12-08 | American Society of Hematology Meeting - Abstract Number: 5236 |
2023-12-08 | American Society of Hematology Meeting - Abstract Number: 5224 |
2023-11-30 14:30 | Piper Sandler Healthcare Conference |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -91,0 -80,8 -12.68% | -132 |
EBIT Million USD | Released Forecast Spread | 0,00 | -47,5 -69,4 31.58% | -91,1 -83,3 -9.46% | -142 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -46,8 -82,4 43.2% | -76,3 -71,8 -6.24% | -119 |
Net income Million USD | Released Forecast Spread | -36,0 | -46,8 -78,6 40.39% | -76,4 -71,4 -7.03% | -119 |
EPS USD | Released Forecast Spread | -4,49 | -45,1 -4,68 -862.61% | -3,42 -3,23 -5.99% | -4,50 |
Announcement Date | 02/09/22 | 31/03/23 | 21/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
EBIT Million USD | Released Forecast Spread | -15,0 -15,2 1.19% | -25,1 -14,7 -71.45% | -17,3 -19,3 10.06% | -19,0 -19,0 0.29% | -29,7 -20,3 -46.65% | -31,5 -27,0 -16.68% | -31,3 | -31,7 | -34,9 | -37,8 | -35,3 | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -11,2 -14,9 24.42% | -22,8 -14,7 -54.36% | -15,9 -18,8 15.52% | -14,1 -17,8 20.99% | -23,5 -19,1 -23.6% | -26,9 -24,4 -10.23% | -29,5 | -29,9 | -33,1 | -37,8 | -35,3 | |
Net income Million USD | Released Forecast Spread | -16,2 | -11,2 -14,1 20.19% | -22,8 -14,1 -61.48% | -15,9 -18,8 15.39% | -14,1 -17,4 18.87% | -23,6 -18,5 -27.17% | -26,9 -25,0 -7.99% | -29,3 | -29,8 | -32,9 | -37,8 | -35,3 |
EPS USD | Released Forecast Spread | -1,86 | -40,9 -0,81 -4981.99% | -1,20 -0,75 -60% | -0,74 -0,91 18.83% | -0,58 -0,76 23.83% | -0,97 -0,77 -25.97% | -1,09 -1,04 -5.14% | -1,11 | -1,11 | -1,20 | -1,29 | -1,31 |
Announcement Date | 23/11/22 | 31/03/23 | 15/05/23 | 11/08/23 | 09/11/23 | 21/03/24 | 09/05/24 | - | - | - | - | - |
2024-07-15 01:45 | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Disc Medicine, Inc.
2024-06-07 02:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
2024-05-29 16:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 17:14 | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 16:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IRON Stock
- Calendar Disc Medicine, Inc.